Literature DB >> 22665365

Urological cancer: For localized prostate cancer, does technology equal progress?

Matthew R Cooperberg.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22665365     DOI： 10.1038/nrclinonc.2012.96

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

Review 1.  Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy.

Authors:  Ashutosh Tewari; Prasanna Sooriakumaran; Daniel A Bloch; Usha Seshadri-Kreaden; April E Hebert; Peter Wiklund
Journal:  Eur Urol       Date:  2012-02-24       Impact factor: 20.096

2.  Outcomes for radical prostatectomy: is it the singer, the song, or both?

Authors:  Matthew R Cooperberg; Anobel Y Odisho; Peter R Carroll
Journal:  J Clin Oncol       Date:  2012-01-03       Impact factor: 44.544

3.  Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come.

Authors:  David S Aaronson; Anobel Y Odisho; Nancy Hills; Rosemary Cress; Peter R Carroll; R Adams Dudley; Matthew R Cooperberg
Journal:  Arch Intern Med       Date:  2012-02-13

Review 4.  High-intensity focused ultrasound for prostate cancer: a systematic review.

Authors:  H Lukka; T Waldron; J Chin; L Mayhew; P Warde; E Winquist; G Rodrigues; B Shayegan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-10-06       Impact factor: 4.126

5.  Re: editorial comment on focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study (lancet oncol 2012; 13: 622-632).

Authors:  Laurence Klotz
Journal:  J Urol       Date:  2012-11-20       Impact factor: 7.450

Review 6.  Active surveillance for prostate cancer: progress and promise.

Authors:  Matthew R Cooperberg; Peter R Carroll; Laurence Klotz
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

7.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

Authors:  Paul L Nguyen; Xiangmei Gu; Stuart R Lipsitz; Toni K Choueiri; Wesley W Choi; Yin Lei; Karen E Hoffman; Jim C Hu
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

8.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

Authors:  Nathan C Sheets; Gregg H Goldin; Anne-Marie Meyer; Yang Wu; YunKyung Chang; Til Stürmer; Jordan A Holmes; Bryce B Reeve; Paul A Godley; William R Carpenter; Ronald C Chen
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272

9.  Comparative effectiveness of minimally invasive vs open radical prostatectomy.

Authors:  Jim C Hu; Xiangmei Gu; Stuart R Lipsitz; Michael J Barry; Anthony V D'Amico; Aaron C Weinberg; Nancy L Keating
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

10.  Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?

Authors:  Andre Konski; William Speier; Alexandra Hanlon; J Robert Beck; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.